Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Altamira Therapeutics Ltd. (CYTO) Receiveable Turnover data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-4.31M |
|
-- |
|
-- |
|
$6.59M |
|
$-6.59M |
|
$-1.51M |
|
$-8.10M |
|
$-8.10M |
|
$-8.10M |
|
$-8.10M |
|
$-4.31M |
|
$-8.10M |
|
$-6.59M |
|
$-6.46M |
|
0.49M |
|
0.49M |
|
$-8.78 |
|
$-8.78 |
|
| Balance Sheet Financials | |
$1.36M |
|
$0.00M |
|
$7.21M |
|
$8.57M |
|
$0.99M |
|
-- |
|
$0.39M |
|
$1.38M |
|
$7.19M |
|
$2.86M |
|
$7.19M |
|
1.48M |
|
| Cash Flow Statement Financials | |
$-12.82M |
|
$1.61M |
|
$11.83M |
|
$0.02M |
|
$0.69M |
|
$0.67M |
|
$0.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-112.56% |
|
-283.43% |
|
-94.49% |
|
-112.56% |
|
$4.87 |
|
$-26.10 |
|
$-26.10 |
|